Congress Park Capital LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Congress Park Capital LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$145,061
-20.5%
112,450
+5.9%
0.08%
-17.6%
Q2 2023$182,578
+20.7%
106,150
+5.9%
0.09%
+15.2%
Q1 2023$151,302
-3.0%
100,200
+395.9%
0.08%
-9.2%
Q1 2021$156,000
-7.7%
20,207
-21.7%
0.09%
-13.0%
Q4 2020$169,000
-67.6%
25,807
-67.2%
0.10%
-69.0%
Q3 2020$522,000
-27.4%
78,561
-9.0%
0.32%
-41.5%
Q2 2020$719,000
-4.9%
86,311
-12.5%
0.55%
-19.1%
Q1 2020$756,000
-3.9%
98,611
+4.2%
0.68%
+17.4%
Q4 2019$787,000
-36.4%
94,661
-43.6%
0.58%
-44.1%
Q3 2019$1,238,000
-27.9%
167,811
-0.5%
1.04%
-23.4%
Q2 2019$1,716,000
-24.5%
168,611
-20.4%
1.36%
-30.9%
Q1 2019$2,274,000
+22.1%
211,906
+71.3%
1.96%
-4.2%
Q4 2018$1,863,000
-10.2%
123,711
+10.3%
2.05%
+10.2%
Q3 2018$2,075,000
-17.1%
112,186
+2.4%
1.86%
-22.5%
Q2 2018$2,504,000
-18.3%
109,525
+1.7%
2.40%
-23.7%
Q1 2018$3,065,000
+15.3%
107,725
-14.5%
3.15%
+17.5%
Q4 2017$2,659,000125,9752.68%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders